Dr Yvonne Lamb to join Norgine as director of global pharmacovigilance
Published on: 08/12/09

Norgine has appointed Dr Yvonne Lamb as director, global pharmacovigilance, with effect from January 25 2010.
A qualified physician, Yvonne has extensive industry experience, serving most recently as pharmacovigilance therapy area head for respiratory at GlaxoSmithKline, prior to which she led the firm’s pharmacovigilance therapy area for neurosciences.
In former roles, she worked in medical evaluation at Roche and as UK medical director at Searle.
She also previously led the UK Clinical Development team for SmithKline Beecham, a role that included a period as medical director for Australia.